Your browser doesn't support javascript.
loading
A strategy for systemic toxicity assessment based on non-animal approaches: The Cosmetics Europe Long Range Science Strategy programme.
Desprez, Bertrand; Dent, Matt; Keller, Detlef; Klaric, Martina; Ouédraogo, Gladys; Cubberley, Richard; Duplan, Hélène; Eilstein, Joan; Ellison, Corie; Grégoire, Sébastien; Hewitt, Nicola J; Jacques-Jamin, Carine; Lange, Daniela; Roe, Amy; Rothe, Helga; Blaauboer, Bas J; Schepky, Andreas; Mahony, Catherine.
Afiliación
  • Desprez B; Cosmetics Europe, Science & Research Department, Avenue Herrmann-Debroux 40, Brussels, Belgium. Electronic address: bdesprez@cosmeticseurope.eu.
  • Dent M; Safety & Environmental Assurance Centre, Unilever U.K. Central Resources Limited, Colworth Science Park, Sharnbrook MK44 1LQ Bedfordshire, UK. Electronic address: matthew.dent@unilever.com.
  • Keller D; HSA-Corporate Scientific Services, Henkel AG & Co. KGaA, 40191 Düsseldorf, Henkelstrasse 67 40589, Germany. Electronic address: detlef.keller@henkel.com.
  • Klaric M; Cosmetics Europe, Science & Research Department, Avenue Herrmann-Debroux 40, Brussels, Belgium. Electronic address: mklaric@cosmeticseurope.eu.
  • Ouédraogo G; L'Oréal Research & Innovation, Advanced Research, Predictive Model and Method Development Department, 1, avenue Eugène Schueller, 93601 Aulnay-sous-Bois, France. Electronic address: GOUEDRAOGO@rd.loreal.com.
  • Cubberley R; Safety & Environmental Assurance Centre, Unilever U.K. Central Resources Limited, Colworth Science Park, Sharnbrook MK44 1LQ Bedfordshire, UK. Electronic address: richard.cubberley@unilever.com.
  • Duplan H; Pierre Fabre Dermo-Cosmétique, Responsable Pharmacologie Division 2 & Pharmacocinétique Cutanée, Centre R&D Pierre Fabre, 3, avenue Hubert Curien, 31035 Toulouse Cedex 1, France. Electronic address: helene.duplan@pierre-fabre.com.
  • Eilstein J; L'Oréal Research & Innovation, Advanced Research, Cutaneous Absorption Team, ADMET, 1, avenue Eugène Schueller, 93601 Aulnay-sous-Bois, France. Electronic address: jeilstein@rd.loreal.com.
  • Ellison C; Global Product Stewardship - Human Safety, Procter & Gamble Mason Business Center, DS3-8A6|8700 Mason Montgomey Road, Mason, OH 45040, USA. Electronic address: ellison.ca@pg.com.
  • Grégoire S; L'Oréal Research & Innovation, Advanced Research, Cutaneous Absorption Team, ADMET, 1, avenue Eugène Schueller, 93601 Aulnay-sous-Bois, France. Electronic address: sgregoire@rd.loreal.com.
  • Hewitt NJ; Cosmetics Europe, Science & Research Department, Avenue Herrmann-Debroux 40, Brussels, Belgium.
  • Jacques-Jamin C; Pierre Fabre Dermo-Cosmétique, Service de Pharmacotissulaire et Pharmacocinétique Cutanée, Centre R&D Pierre Fabre, 3, avenue Hubert Curien, 31035 Toulouse Cedex 1, France. Electronic address: Carine.jacques@pierre-fabre.com.
  • Lange D; Beiersdorf AG, Research & Development, Unnastrasse 48, 20245 Hamburg, Germany. Electronic address: Daniela.Lange@beiersdorf.com.
  • Roe A; The Procter & Gamble Company, Product Safety & Regulatory Affairs, Cincinnati, OH, USA. Electronic address: roe.al@pg.com.
  • Rothe H; Coty, Berliner Allee 65, 64295 Darmstadt, Germany. Electronic address: Helga_Rothe@cotyinc.com.
  • Blaauboer BJ; Institute for Risk Assessment Sciences, Division of Toxicology, University of Utrecht, Utrecht, P.O. Box 80.177, 3508 TD Utrecht, The Netherlands. Electronic address: b.blaauboer@uu.nl.
  • Schepky A; Beiersdorf AG, Research & Development, Unnastrasse 48, 20245 Hamburg, Germany. Electronic address: Andreas.Schepky@Beiersdorf.com.
  • Mahony C; Procter & Gamble Technical Centres Ltd, Rusham Park Whitehall Lane TW20 9NW, Egham, Surrey, UK. Electronic address: mahony.c@pg.com.
Toxicol In Vitro ; 50: 137-146, 2018 Aug.
Article en En | MEDLINE | ID: mdl-29499337
ABSTRACT
When performing safety assessment of chemicals, the evaluation of their systemic toxicity based only on non-animal approaches is a challenging objective. The Safety Evaluation Ultimately Replacing Animal Test programme (SEURAT-1) addressed this question from 2011 to 2015 and showed that further research and development of adequate tools in toxicokinetic and toxicodynamic are required for performing non-animal safety assessments. It also showed how to implement tools like thresholds of toxicological concern (TTCs) and read-across in this context. This paper shows a tiered scientific workflow and how each tier addresses the four steps of the risk assessment paradigm. Cosmetics Europe established its Long Range Science Strategy (LRSS) programme, running from 2016 to 2020, based on the outcomes of SEURAT-1 to implement this workflow. Dedicated specific projects address each step of this workflow, which is introduced here. It tackles the question of evaluating the internal dose when systemic exposure happens. The applicability of the workflow will be shown through a series of case studies, which will be published separately. Even if the LRSS puts the emphasis on safety assessment of cosmetic relevant chemicals, it remains applicable to any type of chemical.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas de Toxicidad / Alternativas a las Pruebas en Animales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Humans País/Región como asunto: Europa Idioma: En Revista: Toxicol In Vitro Asunto de la revista: TOXICOLOGIA Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pruebas de Toxicidad / Alternativas a las Pruebas en Animales Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals / Humans País/Región como asunto: Europa Idioma: En Revista: Toxicol In Vitro Asunto de la revista: TOXICOLOGIA Año: 2018 Tipo del documento: Article
...